查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1208615

2023-2030 年全球视力保健设备市场

Global Vision Care Devices Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

视力保健设备的全球市场规模预计将在 2022 年达到 124 亿美元，到 2030 年达到 247.8 亿美元，预测期内（2023 年至 2030 年）的复合年增长率为 12.7%。预计还会增长。

视力保健设备是用于增强或维持视力的医疗设备。 它们可以通过手术永久植入眼眶或临时使用。 这些视力保健设备可能会或可能不会被开具处方，并且可以长期使用。

市场动态

推动全球视力保健设备市场发展的主要因素是青光眼、年龄相关性黄斑变性 (AMD)、白内障等眼病发病率的增加、技术进步以及视力保健设备的新产品发布。需求增加

提高认识的努力和新技术先进视力保健设备的兴起预计将推动市场的增长。

随着技术的不断进步、老年人口的增加、研发投资的激增、青光眼、白内障和 AMD 等眼病患病率的增加以及新兴市场医疗基础设施的改善，视力保健设备市场正在采用最新技术。通过新产品的改进。

视力保健设备用于给药和美容目的。 这些设备的采用正在增加，政府的努力和资金也在增加。 这些资金将用于生产人工晶状体、眼科激光和青光眼治疗设备等视力保健设备产品。 随着眼科疾病的增加，这些应用的市场正在全球范围内扩大。 此外，预计主要製造商提供的技术先进的产品也将在市场增长中发挥重要作用。

与这些视力保健设备相关的各种新产品发布、研究和提高认识活动正在促进市场的增长。 例如，2022 年 8 月，植入式镜片和输送系统的设计者和供应商 STAAR Surgical Company 宣布了其最新的植入式镜片 EVO Visian，这是一种经 FDA 批准的视力矫正镜片，用于矫正散光和近视。我们宣布推出一款与演员兼歌手乔乔纳斯 (Joe Jonas) 建立新的合作伙伴关係，以提高人们对 Kata Colla Mellens 的认识。

与视力保健设备批准相关的产品召回和严格法规预计会阻碍市场增长。

关于批准用于视力保健的多种设备的严格规章制度是阻碍视力保健设备市场增长的主要因素。 由于必须满足的各种要求，这些植入物的总成本增加了。 由于产品中所含器官的脆弱性，高成本和风险会阻碍生长。

市场召回也是製约市场增长的主要因素。 由于洩漏和并发症，已经有几次召回。 例如，2022 年 10 月，罗氏公司因製造相关问题召回了其植入物 Susvimo。 Susvimo 是一种经批准的植入物，可将雷珠单抗输送至湿性年龄相关性黄斑变性患者的眼睛。 输送装置的隔膜或密封件存在製造问题，无法防止药物洩漏。

COVID-19 影响分析

疫情对全球金融预期、运营和危机应对策略产生了负面影响。 COVID-19 的爆发严重影响了医疗保健行业。 由于 COVID，视力保健设备市场遭受了巨大损失。 主要製造商已经启动了各种研究和临床试验。 世界各地正在开展各种举措、产品发布、合作和合併，以促进市场的增长。 例如，2020 年 7 月，植入式镜片和输送系统的设计者和供应商 STAAR Surgical Company 获得了 EVO Viva/EVO Visian ICL 的 CE 标誌，这是一种用于矫正老花眼的新颖的植入式领型镜片。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 提高人们对视力保健设备的认识
      • 不断进步的技术进步
    • 约束因素
      • 与视力保健设备相关的产品召回
    • 商机
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 定价分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 人工晶状体
    • 单焦点人工晶状体
    • 多焦点人工晶状体
    • 可调节人工晶状体
    • 復曲面人工晶状体
  • 眼镜
  • 隐形眼镜
    • 一次性隐形眼镜
    • 特殊隐形眼镜
    • 透气性隐形眼镜
  • 青光眼引流装置
  • 眼科激光
  • 商业眼保健品
  • 其他

第 8 章按类型

  • 处方药
  • 非处方药（非处方药）

第9章应用

  • 眼科手术
    • 青光眼
    • 年龄相关性黄斑变性
    • 白内障手术后
    • 眼科手术后
    • 视网膜疾病
  • 诊断
  • 眼部护理
  • 其他

第 10 章最终用户

  • 医院
  • 门诊手术中心
  • 眼科诊所
  • 其他

第11章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第12章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 产品基准
  • 值得关注的主要公司名单

第13章公司简介

  • 诺华公司
    • 公司概况
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • CooperVision
  • Johnson & Johnson Services, Inc.
  • Alcon
  • Bausch & Lomb Incorporated.
  • Carl Zeiss
  • Ophtec BV
  • MORCHER GmbH
  • Safilo Group S.p.A
  • EssilorLuxottica

第14章 DataM

简介目录
Product Code: DMMD96

Market Overview

The global vision care devices market size was valued at US$ 12.4 billion in 2022 and is estimated to reach US$ 24.78 billion by 2030, growing at a CAGR of 12.7% during the forecast period (2023-2030).

Vision care devices are medical device that is used for enhancing and maintaining vision. These can be surgically embedded inside the socket of the eye permanently or can be used temporarily. These vision care devices can be prescribed or non-prescribed and can be used for an extended period of time.

Market Dynamics

The major factors driving the global vision care devices market are the rising demand for vision care devices owing to increasing incidences of ophthalmic disorders such as glaucoma, age-related macular degeneration (AMD) and cataract, technological advancements and novel product launches.

The increasing awareness initiatives and rising novel technologically advanced vision care devices are expected to drive the market's growth.

The vision care devices market is driven by rising advancements in technology, an increase in the geriatric population, a surge in research and development investments, an increasing number of ophthalmic disorders such as glaucoma, cataract, AMD and improvements in novel products using the latest technology along with improvements in medical infrastructure in emerging markets.

The vision care devices are used for delivering drugs and aesthetic purposes. The adoption of these devices is increasing, leading to rising government initiatives and funds. These funds will help produce vision care devices products such as intraocular lenses, ophthalmic laser or glaucoma drainage devices. The market for these applications is increasing worldwide due to the enhanced number of these ophthalmic disorders. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market's growth.

Various novel product launches, research studies, and rising awareness initiatives related to these vision care devices contribute to the market's growth. For instance, in August 2022, STAAR Surgical Company, a designer and provider of implantable lenses and delivery systems, announced its new partnership with Joe Jonas, an actor and singer, to create awareness of its latest implantable Collamer lenses, EVO Visian, an FDA-approved lens for vision correction developed for astigmatism and myopia correction.

Product recalls and stringent regulations associated with the approval of vision care devices are expected to hamper the market's growth.

Strict rules and regulations for the approval of several devices utilized for vision care is the major factor hindering the growth of the vision care devices market. Various requirements must be fulfilled, leading to an increase in the overall cost of these implants. The high cost and risks involved due to the sensitivity of the organ in the product are likely to hinder the growth.

Market recalls are also a leading factor restraining the growth of the market. Several recalls are taking place due to leakage or complications. For instance, in October 2022, Roche recalled its implant Susvimo due to a manufacturing-related issue. Susvimo is an approved implant that delivers ranibizumab into the eye of people with wet age-related macular degeneration. The septum or seal of the delivery device has some manufacturing issues and cannot keep the medicine from leaking out.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The Vision Care Devices market has experienced huge losses due to COVID. Key manufacturers have started various research and clinical trials. Various initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in July 2020, STAAR Surgical Company, a designer and provider of implantable lenses and delivery systems, announced its novel, innovative implantable Collamer lens, EVO Viva/ EVO Visian ICL, for presbyopia correction, received CE Mark.

Segment Analysis

The Intraocular lenses segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The intraocular lenses segment is the highest market holder in the global vision care devices market. The global vision care devices market is segmented based on product type as intraocular lenses, eye-glasses, contact lenses, glaucoma drainage devices, ophthalmic lasers, over-the-counter eye care/ supplements and others. The intraocular lenses segment is the largest market shareholder due to its inherent advantages over other implants or devices, increasing technological advancements and novel product launches.

Intraocular lenses are artificial lenses implanted into the eye for myopia or cataract treatment purposes. It replaces the natural lens of the eye removed during the surgery and restores distant or near vision. These lenses are of various types: accommodating, mono-focal, multifocal, and toric. One of the leading causes of blindness is cataracts which can be treated with the help of these implants through surgery.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, in September 2022, Johnson and Johnson Vision, part of Johnson and Johnson Medtech and an eye health company, introduced their novel intraocular lens powered by InteliLight technology and TECNIS symphony OptiBlue intraocular lens for correcting presbyopia. This lens with depth of focus joins the hybrid lens, TECNIS synergy intraocular lens, for spectacle independence in the InteliLight portfolio. This corrects presbyopia in more patients. These deliver low-light performance and superior contrast in this intraocular lens category.

Geographical Analysis

North America holds the largest market share in the global vision care devices market.

North America dominates the global vision care devices market primarily due to its large population, excellent medical infrastructure, and high-income levels. The market is expected to grow at a relatively moderate pace during the forecast period due to healthcare expenditure in the US. The market's significant size is attributed to the high medical expenditure.

Increasing expenditure on healthcare and raising awareness among people is also contributing to the market's growth in this region. Advancement of vision care devices applications in several ophthalmic conditions, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the vision care devices market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in Aug 2020, Johnson & Johnson Vision, a company focusing on eye health, announced that its TECNIS Eyhance and TECNIS synergy intraocular lenses for cataract treatment got approved by Health Canada and will be available in the Canadian market.

Competitive Landscape

The vision care devices market is highly competitive with local and global companies' presence. Novartis Inc., Cooper Vision, Johnson & Johnson Services, Inc., STAAR Surgical, Bausch & Lomb Incorporated., Carl Zeiss, Ophtec BV, MORCHER GmbH, Safilo Group S.p.A, EssilorLuxottica and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in July 2022, Bausch + Lomb Corporation, an eye health company and Sanoculis, an ophthalmic device company, announced their strategic agreements developed to focus on glaucoma's unmet needs.

Novartis AG

Overview: Novartis is engaged in discovering, developing, manufacturing, and selling a wide range of pharmaceutical and generic medicines. The company has two operating divisions globally: Innovative medicines and Sandoz for biosimilars and generic pharmaceuticals.

Product Portfolio:

Clareon intraocular lens: This has an advanced, disposable and pre-loaded delivery system optic Type. It can be implanted with a delivery system that is unique and automated.

Key Development: In June 2022, Novartis announced its acquisition of Kedalion Therapeutics along with its innovative AcuStream technology, a device that can provide accurate delivery with precise dosing of ophthalmic medications. This acquisition will expand the ophthalmic portfolio of Novartis.

The global vision care devices market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing awareness initiatives for these vision care devices
      • 4.1.1.2. Rising technological advancements
    • 4.1.2. Restraints:
      • 4.1.2.1. Product recalls associated with vision care devices
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Intraocular Lenses *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 7.2.3. Monofocal IOLs
    • 7.2.4. MultifocalIOLs
    • 7.2.5. Accommodating IOLs
    • 7.2.6. Toric IOLs
  • 7.3. Eye Glasses
  • 7.4. Contact Lenses
    • 7.4.1. Disposable Contact Lenses
    • 7.4.2. Specialty Contact Lenses
    • 7.4.3. Gas Permeable Contact Lenses
  • 7.5. Glaucoma Drainage Devices
  • 7.6. Ophthalmic Lasers
  • 7.7. Over-the-counter Eye Care/ Supplements
  • 7.8. Others

8. By Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.1.2. Market Attractiveness Index, By Type
  • 8.2. Prescription *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Non-Prescription (Over-the-counter)

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Optical Surgeries *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 9.1.1. Glaucoma
    • 9.1.2. Age-related Macular Degeneration
    • 9.1.3. Post-Cataract Surgery
    • 9.1.4. Post Ocular Surgery
    • 9.1.5. Retinal Conditions
  • 9.2. Diagnosis
  • 9.3. Eye Care
  • 9.4. Others

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Ambulatory Surgical Centers
  • 10.4. Eye Specialty Clinics
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Products Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. Novartis AG *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. CooperVision
  • 13.3. Johnson & Johnson Services, Inc.
  • 13.4. Alcon
  • 13.5. Bausch & Lomb Incorporated.
  • 13.6. Carl Zeiss
  • 13.7. Ophtec BV
  • 13.8. MORCHER GmbH
  • 13.9. Safilo Group S.p.A
  • 13.10. EssilorLuxottica

LIST NOT EXHAUSTIVE

14. Global Vision Care Devices Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Application
  • 14.3. Contact Us